tiprankstipranks
Cytokinetics (CYTK)
NASDAQ:CYTK

Cytokinetics (CYTK) Financial Statements

976 Followers

Cytokinetics Financial Overview

Cytokinetics's market cap is currently ―. The company's EPS TTM is $-5.403; its P/E ratio is -10.44; Cytokinetics is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-1.05. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 835.00K$ 1.67M$ 378.00K$ 867.00K$ 4.61M
Gross Profit$ -80.73M$ -162.72M$ 378.00K$ 867.00K$ 4.61M
EBIT$ -118.32M$ -119.83M$ -115.43M$ -115.27M$ -118.05M
EBITDA$ -115.99M$ -113.50M-$ -117.28M$ -119.24M
Net Income Common Stockholders$ -135.64M$ -136.90M$ -129.42M$ -128.64M$ -131.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 618.96M$ 614.82M$ 539.24M$ 565.72M$ 663.96M
Total Assets$ 808.08M$ 824.32M$ 740.61M$ 779.90M$ 889.82M
Total Debt$ 205.13M$ 206.78M$ 200.34M$ 202.02M$ 203.71M
Net Debt$ -413.83M$ -408.04M$ -338.90M$ -363.70M$ -460.25M
Total Liabilities$ 1.20B$ 1.21B$ 1.18B$ 1.11B$ 1.12B
Stockholders Equity$ -396.16M$ -386.32M$ -438.80M$ -333.12M$ -229.02M
Cash Flow-
Free Cash Flow$ -129.50M$ -74.11M-$ -122.52M$ -122.69M
Operating Cash Flow$ -129.50M$ -74.04M$ -96.20M$ -121.81M$ -122.29M
Investing Cash Flow$ 32.64M$ -81.41M$ 73.04M$ 82.13M$ 165.50M
Financing Cash Flow$ 103.79M$ 168.80M$ 54.22M$ 5.47M$ -7.18M
Currency in USD

Cytokinetics Earnings and Revenue History

Cytokinetics Debt to Assets

Cytokinetics Cash Flow

Cytokinetics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis